Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Nicolas

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 StudyChristopher Eigler, Lisa McDougall, Andreas Bauman, et al.
Arthritis and Rheumatism|September 2, 2008
Attributable risk of carpal tunnel syndrome according to industry and occupation in a general populationYves Roquelaure, Catherine Ha, Guillaume Nicolas, et al.
Experimental Neurology|September 21, 2010
Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutationsJulien Cassereau, Arnaud Chevrollier, Naïg Gueguen, et al.
Clinical Nuclear Medicine|June 20, 2020
Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor ImagingKwadwo Antwi, Matthias Hepprich, Natasha A Müller, et al.
Neurology|May 14, 2013
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathyJean-Marc Léger, Karine Viala, Guillaume Nicolas, et al.
Clinical Nuclear Medicine|August 19, 2015
Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine TumorsBrian P Riff, Yu-Xiao Yang, Michael C Soulen, et al.
Neuromuscular Disorders : NMD|September 3, 2019
X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contracturesMarion Brisset, Rabah Ben Yaou, Robert-Yves Carlier, et al.
Neuro-Oncology|April 24, 2016
Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptakeKatharina Seystahl, Veit Stoecklein, Ulrich Schüller, et al.
Journal of Medical Genetics|October 9, 2010
Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencingKaren Gaudon, Isabelle Pénisson-Besnier, Brigitte Chabrol, et al.
Clinical Neurology and Neurosurgery|May 9, 2026
Feasibility and usefulness of personalised patient-reported outcome measures in the therapeutic follow-up of adult spinal muscular atrophy patientsPascal Cintas, Samuel Pouplin, Louise Debergé, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 29, 2024
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 StudyChristopher Eigler, Lisa McDougall, Andreas Bauman, et al.
Arthritis and Rheumatism|September 2, 2008
Attributable risk of carpal tunnel syndrome according to industry and occupation in a general populationYves Roquelaure, Catherine Ha, Guillaume Nicolas, et al.
Experimental Neurology|September 21, 2010
Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutationsJulien Cassereau, Arnaud Chevrollier, Naïg Gueguen, et al.
Clinical Nuclear Medicine|June 20, 2020
Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor ImagingKwadwo Antwi, Matthias Hepprich, Natasha A Müller, et al.
Neurology|May 14, 2013
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathyJean-Marc Léger, Karine Viala, Guillaume Nicolas, et al.
Clinical Nuclear Medicine|August 19, 2015
Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine TumorsBrian P Riff, Yu-Xiao Yang, Michael C Soulen, et al.
Neuromuscular Disorders : NMD|September 3, 2019
X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contracturesMarion Brisset, Rabah Ben Yaou, Robert-Yves Carlier, et al.
Neuro-Oncology|April 24, 2016
Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptakeKatharina Seystahl, Veit Stoecklein, Ulrich Schüller, et al.
Journal of Medical Genetics|October 9, 2010
Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencingKaren Gaudon, Isabelle Pénisson-Besnier, Brigitte Chabrol, et al.
Clinical Neurology and Neurosurgery|May 9, 2026
Feasibility and usefulness of personalised patient-reported outcome measures in the therapeutic follow-up of adult spinal muscular atrophy patientsPascal Cintas, Samuel Pouplin, Louise Debergé, et al.
Pageof 10